News | June 29, 2024
Aurobindo Pharma’s subsidiary acquires Ace Laboratories, UK
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
This tie-up will have no impact on any other brands of the company
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Combined entity is better positioned to compete in increasingly competitive generics industry
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
The company will now explore a buyer for its manufacturing site and exit in due course
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients
Subscribe To Our Newsletter & Stay Updated
